Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillem Montamat Garcia

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Immunity|June 9, 2026
Exhaustion in name only: CD8<sup>+</sup> T cells drive lupus nephritisGuillem Montamat-Garcia, Claudia Mauri
Frontiers in Immunology|July 4, 2025
Tumor necrosis factor receptor 2 in allergen tolerance: a perspective viewGuillem Montamat-Garcia, Murilo Luiz Bazon, Agnieszka Demczuk, et al.
Nature Methods|November 6, 2023
sciCSR infers B cell state transition and predicts class-switch recombination dynamics using single-cell transcriptomic dataJoseph C F Ng, Guillem Montamat Garcia, Alexander T Stewart, et al.
Cell Reports. Medicine|June 4, 2026
Human primary antibody response to vaccination follows a partially sequential class-switching program with a checkpoint at IGHG2Guillem Montamat-Garcia, Joseph C F Ng, Alexander T Stewart, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Immunity|June 9, 2026
Exhaustion in name only: CD8<sup>+</sup> T cells drive lupus nephritisGuillem Montamat-Garcia, Claudia Mauri
Frontiers in Immunology|July 4, 2025
Tumor necrosis factor receptor 2 in allergen tolerance: a perspective viewGuillem Montamat-Garcia, Murilo Luiz Bazon, Agnieszka Demczuk, et al.
Nature Methods|November 6, 2023
sciCSR infers B cell state transition and predicts class-switch recombination dynamics using single-cell transcriptomic dataJoseph C F Ng, Guillem Montamat Garcia, Alexander T Stewart, et al.
Cell Reports. Medicine|June 4, 2026
Human primary antibody response to vaccination follows a partially sequential class-switching program with a checkpoint at IGHG2Guillem Montamat-Garcia, Joseph C F Ng, Alexander T Stewart, et al.
Pageof 1